Clinical Trial Update: Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise [Phase 3]

View source ↗

Summary

Phase 3 study evaluating BMS-477118 as monotherapy with titration in adults with Type 2 diabetes not controlled by diet and exercise; the trial is completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BMS-477118

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2009-09-25